The Motley FoolIf You Invested $10,000 in Gilead Sciences' IPO, This Is How Much Money You'd Have NowApr 20, 2020Keith SpeightsBy Keith Speightsmore_vert
Chemical & Engineering NewsScaling up remdesivir amid the coronavirus crisisApr 20, 2020Lisa JarvisBy Lisa Jarvismore_vert